The Cooper Companies, Inc. (NASDAQ:COO) Given Consensus Rating of "Moderate Buy" by Brokerages

The Cooper Companies, Inc. (NASDAQ:COO - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the eleven research firms that are covering the stock, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. The average 1 year target price among brokers that have covered the stock in the last year is $99.70.

COO has been the topic of a number of research reports. UBS Group raised shares of Cooper Companies to a "buy" rating in a report on Tuesday, June 17th. BNP Paribas upgraded shares of Cooper Companies to a "hold" rating in a report on Thursday, March 13th. Robert W. Baird reduced their price objective on shares of Cooper Companies from $107.00 to $97.00 and set an "outperform" rating on the stock in a research note on Friday, May 30th. Citigroup decreased their price objective on Cooper Companies from $115.00 to $110.00 and set a "buy" rating for the company in a report on Friday, March 7th. Finally, Wells Fargo & Company lowered their target price on Cooper Companies from $118.00 to $93.00 and set an "overweight" rating for the company in a research report on Friday, May 30th.

Cooper Companies Trading Up 0.3%

NASDAQ COO opened at $73.02 on Thursday. The company has a market cap of $14.60 billion, a price-to-earnings ratio of 35.45, a price-to-earnings-growth ratio of 1.78 and a beta of 0.99. Cooper Companies has a twelve month low of $65.00 and a twelve month high of $112.38. The company has a quick ratio of 1.23, a current ratio of 2.10 and a debt-to-equity ratio of 0.30. The business's fifty day moving average is $75.97 and its 200 day moving average is $83.62.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its earnings results on Thursday, May 29th. The medical device company reported $0.96 EPS for the quarter, beating the consensus estimate of $0.93 by $0.03. The firm had revenue of $1 billion during the quarter, compared to the consensus estimate of $995.12 million. Cooper Companies had a return on equity of 9.60% and a net margin of 10.39%. The business's quarterly revenue was up 6.3% on a year-over-year basis. During the same period last year, the company earned $0.85 earnings per share. As a group, sell-side analysts expect that Cooper Companies will post 3.98 EPS for the current fiscal year.

Institutional Trading of Cooper Companies

Large investors have recently bought and sold shares of the business. OFI Invest Asset Management acquired a new position in shares of Cooper Companies in the 4th quarter valued at about $34,000. Zions Bancorporation National Association UT bought a new stake in Cooper Companies in the first quarter worth approximately $33,000. City Holding Co. bought a new stake in Cooper Companies in the first quarter worth approximately $34,000. New Age Alpha Advisors LLC acquired a new position in Cooper Companies in the fourth quarter valued at approximately $38,000. Finally, Covestor Ltd boosted its holdings in shares of Cooper Companies by 35.5% during the 4th quarter. Covestor Ltd now owns 458 shares of the medical device company's stock worth $42,000 after buying an additional 120 shares in the last quarter. 24.39% of the stock is currently owned by institutional investors and hedge funds.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.